ZoomInfo (ZI) Explodes on Strong Q2 Results and Guidance, Analysts Bulled Up with 10 PT Hikes

ZoomInfo Technologies Inc. (ZI) Upsizes Secondary Offering to 27M Shares from 20M Shares

ZoomInfo Technologies Inc. (NASDAQ: ZI) today announced an upsizing of the previously announced underwritten secondary offering by certain selling stockholders of ZoomInfo, including investment funds affiliated with TA Associates (TA), The Carlyle Group (Carlyle) and 22C Capital LLC (22C Capital) and an entity affiliated with ZoomInfos co-founders (together with TA, Carlyle and 22C Capital, the Selling Stockholders), to 27,000,000 shares of ZoomInfos Class A common stock pursuant to ZoomInfos... More

ZoomInfo Technologies (ZI) PT Raised to $70 at Stifel

Stifel analyst Parker Lane raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $70.00 (from $65.00) while maintaining a Buy rating.... More

Pre-Open Stock Movers 08/03: (OTLK) (TBIO) (HOLI) Higher; (CLX) (RNA) (KOPN) Lower (more...)

Pre-Open Stock Movers:

Outlook Therapeutics, Inc. (Nasdaq: OTLK) 34.5% HIGHER; announced positive clinical and highly statistically significant top-line results from its pivotal Phase 3 NORSE TWO safety and efficacy trial evaluating ONS-5010 / LYTENAVA (bevacizumab) for treatment of neovascular age-related macular degeneration (wet AMD). Outlook Therapeutics will host a conference call and webcast today, August 3, 2021, at 8:00 a.m. ET (details below) to discuss the results of the study.

Translate Bio (NASDAQ: TBIO) 29.2% HIGHER; As part of Sanofis endeavor to... More

ZoomInfo Technologies (ZI) PT Raised to $80 at Morgan Stanley

Morgan Stanley analyst Stan Zlotsky raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $80.00 (from $75.00) while maintaining a Overweight rating and seeing a 4:1 bull/bear risk/reward skew. The company reported accelerating growth momentum in Q2 across organic revenue, billings and cRPO bookings. Cash... More

ZoomInfo Technologies (ZI) PT Raised to $70 at Canaccord Genuity

Canaccord Genuity analyst David Hynes Jr. raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $70.00 (from $65.00) while maintaining a Buy rating.... More

ZoomInfo Technologies (ZI) PT Raised to $75 at BofA Securities

BofA Securities analyst Brad Sills raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $75.00 (from $70.00) while maintaining a Buy rating.

ZoomInfo Technologies (ZI) PT Raised to $70 at Raymond James

Raymond James analyst Brian Peterson raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $70.00 (from $62.00) while maintaining a Outperform rating.... More

ZoomInfo Technologies (ZI) PT Raised to $80 at Truist Securities

Truist Securities raised its price target on ZoomInfo Technologies (NASDAQ: ZI) to $80.00 (from $70.00) while maintaining a Buy rating.... More

ZoomInfo Technologies (ZI) PT Raised to $60 at Deutsche Bank

Deutsche Bank analyst Taylor McGinnis raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $60.00 (from $54.00) while maintaining a Hold rating.... More

ZoomInfo Technologies (ZI) PT Raised to $70 at Mizuho Securities

Mizuho Securities analyst Siti Panigrahi raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $70.00 (from $63.00) while maintaining a Buy rating.... More

ZoomInfo Technologies (ZI) PT Raised to $76 at Wells Fargo

Wells Fargo analyst Michael Turrin raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $76.00 (from $64.00) while maintaining a Overweight rating.... More

ZoomInfo Technologies (ZI) PT Raised to $66 at Barclays

Barclays analyst Raimo Lenschow raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $66.00 (from $59.00) while maintaining a Equalweight rating.... More

UPDATE: RBC Capital Assumes ZoomInfo Technologies (ZI) at Outperform

(Updated - August 3, 2021 4:29 AM EDT)

RBC Capital analyst Rishi Jaluria assumes coverage on ZoomInfo Technologies (NASDAQ: ZI) with a Outperform rating and a price target of $70.00 (from $60.00).

The analyst comments "ZI posted a strong beat-and-raise quarter with full year guidance... More

ZoomInfo Technologies Inc. (ZI) Tops Q2 EPS by 2c, Raises Guidance

ZoomInfo Technologies Inc. (NASDAQ: ZI) reported Q2 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $174 million versus the consensus estimate of $162.34 million.

GUIDANCE:

ZoomInfo Technologies Inc. sees Q3 2021 EPS of $0.11-$0.12, versus the consensus... More